Literature DB >> 35433398

Vasoactive-inotropic score and pediatric septic shock mortality: Correspondence.

Pathum Sookaromdee1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Year:  2022        PMID: 35433398      PMCID: PMC9008283          DOI: 10.4103/ijciis.ijciis_100_21

Source DB:  PubMed          Journal:  Int J Crit Illn Inj Sci        ISSN: 2229-5151


× No keyword cloud information.
Dear Editor, We would like to share ideas on “Validation of the vasoactive-inotropic score in predicting pediatric septic shock mortality: A retrospective cohort study.”[1] Pudjiadi et al. concluded that “vasoactive-inotropic score VIS >11 has a good ability to predict mortality in children with septic shock.”[1] We agree that vasoactive-inotropic score might be a good predictive clinical parameter. However, there are some concerns. First, mortality depends on several factors including the treatment given to the patient. Second, an inclusion criteria for subjects “1 month to 18 years” means heterogenicity of participants. Pathophysiology in small children is different from late adolescence. Finally, the reliability of the vasoactive-inotropic score is still an issue for assessment.[2] Pitfalls are reported and the important limitation of the score is no universally recognized version that consists of all commonly used vasoactive drugs.[3]

Research quality and ethics statement

This letter did not require approval by the Institutional Review Board / Ethics Committee. No specific EQUATOR Network (http://www.equator-network.org/) guidelines are available for letters to the editor.

Financial support and sponsorship

Nil.

Conflict of interest

None.
  3 in total

1.  Vasoactive-Inotropic Score: Is It Reliable in Pediatric Sepsis as a Predictive Outcome Measure?

Authors:  José Colleti; Werther Brunow de Carvalho
Journal:  Pediatr Crit Care Med       Date:  2017-10       Impact factor: 3.624

2.  Validation of the vasoactive-inotropic score in predicting pediatric septic shock mortality: A retrospective cohort study.

Authors:  Antonius Hocky Pudjiadi; Dwi Lestari Pramesti; Sudung O Pardede; Mulyadi M Djer; Rinawati Rohsiswatmo; Nastiti Kaswandani
Journal:  Int J Crit Illn Inj Sci       Date:  2021-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.